🇺🇸 FDA
Patent

US 9241896

Methods and formulations for treating sialic acid deficiencies

granted A61KA61K31/7012A61K9/0002

Quick answer

US patent 9241896 (Methods and formulations for treating sialic acid deficiencies) held by Ultragenyx Pharmaceutical Inc. expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7012, A61K9/0002, A61K9/205, A61K9/2054